Results 161 to 170 of about 6,510 (175)
Some of the next articles are maybe not open access.

Novel cell-permeable PARG inhibitors are selective and sensitize cells to alkylating DNA damage

European Journal of Cancer, 2016
D. James   +9 more
openaire   +1 more source

284 Poly(ADP-ribose) glycohydrolase (PARG) inhibitors increase nuclear poly(ADP-ribose) after methylating DNA damage

European Journal of Cancer, 2014
A. Jordan   +15 more
openaire   +1 more source

Correction: Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality

2019
Gogola, Ewa   +26 more
openaire   +2 more sources

352 (PB340): Covalent PARG inhibitors show sustained target engagement and superior anticancer activity

European Journal of Cancer
S. Patra   +8 more
openaire   +1 more source

The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase

Nature, 2011
Dea Slade, Mark S Dunstan, Pierre Lafite
exaly  

355 (PB343): Preclinical Candidate SYN608 - a Novel PARG Inhibitor with Excellent Anti-tumor Activity

European Journal of Cancer
S. Shi   +7 more
openaire   +1 more source

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly  

PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion

FASEB Journal, 2005
S Cuzzocrea   +2 more
exaly  

Home - About - Disclaimer - Privacy